• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Jamshidi Bone Marrow Biopsy/Aspiration Needle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Jamshidi Bone Marrow Biopsy/Aspiration Needlesee related information
Date Initiated by FirmMarch 17, 2020
Create DateApril 09, 2020
Recall Status1 Terminated 3 on July 15, 2024
Recall NumberZ-1689-2020
Recall Event ID 85338
510(K)NumberK171531 
Product Classification Instrument, biopsy - Product Code KNW
ProductJamshidi Bone Marrow Biopsy/Aspiration Needle, with Luer Lock Adapter 11GX4 ASP, Sterile - Product Code: DJ4011X - Product Usage: The device is comprised of an outer cannula with a handle and an inner stylet. Its intended use is for the posterior iliac crest biopsy technique.
Code Information Lot Numbers: 0001303256 and 0001303257
FEI Number 2020394
Recalling Firm/
Manufacturer
Bard Peripheral Vascular Inc
1625 W 3rd St Bldg 1
Tempe AZ 85281-2438
For Additional Information ContactSAME
480-303-2602
Manufacturer Reason
for Recall
Sterility compromised due to packaging pouches that may not be sealed properly
FDA Determined
Cause 2
Packaging process control
ActionBecton, Dickinson and Company (BD) issued notification on 3/17/20 stating reason for recall, health risk, and action to take: check all inventory locations within your institution for affected product code / lot number combinations listed in the recall notice. If you have further distributed any of the product code / lot numbers, immediately contact that location, advise them of the recall, forward these instructions and have them complete the instructions within this recall notice. 3. Please remove any identified product from your shelves. 4. Destroy all identified product from the affected product code / lot number combinations following your institutions process for destruction. 5. If you have used the affected product, complete and return the attached Recall and Effectiveness Check Form indicating that you do not have affected product in inventory. Once the product affected by this recall has been removed from your inventory and destroyed: 6. Fill out the Recall and Effectiveness Check Form. Be sure to state the quantities and lot numbers of each recalled product that you destroyed. It is extremely important that we receive this information. 7. Email the completed Recall and Effectiveness Check Form to BD Regulatory Compliance at BDRC5@bd.com or fax it to 312-949-0229. 8. Once the Recall and Effectiveness Check Form has been completed and emailed to BD Regulatory Compliance at BDRC5@bd.com or faxed to 312-949-0229 and all information has been verified, BD will issue you a product replacement for any destroyed inventory. Please call our BD Customer/Technical Support at 800-638-8663 with any questions.
Quantity in Commerce8,170 units (US: 420 and OUS: 7,750)
DistributionWorldwide distribution - US Nationwide distribution in the states of FL, IL, NJ, NY, OH, TN, VA and countries of AUSTRALIA, INDIA, JAPAN, MALAYSIA, NEW ZEALAND, PHILIPPINES and SINGAPORE.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database510(K)s with Product Code = KNW
-
-